Status:
UNKNOWN
An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.
Lead Sponsor:
National University Hospital, Singapore
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Urinary Tract Infections
Eligibility:
All Genders
21-70 years
Brief Summary
The aim of this study is to determine the outcomes when using ertapenem for complicated urinary tract infections in the OPAt setting. The study hypothesis: Ertapenem is an efficacious and safe therap...
Detailed Description
Enterobactericae spp. is a common cause of urinary tract infections. The prevalence of quinolone-resistance in Enterobactericae is rising and often co-exists with expression of extended-spectrum beta-...
Eligibility Criteria
Inclusion
- Adult patients between 21 years old to 70 years old.
- Diagnosed with complicated urinary tract infection due to pathogen susceptible to ertapenem based on microbiology report, and the use of ertapenem is deemed clinically appropriate by the Infectious Disease physician in charge.
Exclusion
- Hypersensitivity reactions to Ertapenem.
- Participation in another interventional clinical investigation within 30days
- Unable to obtain informed consent.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01173068
Start Date
August 1 2010
End Date
September 1 2014
Last Update
April 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, Singapore, 119074